Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts-Reference-Cited by-同舟云学术

Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts

Published:2021-04-20 Issue:5 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Pollock Nira R.¹^ORCID,Jacobs Jesica R.²³,Tran Kristine²,Cranston Amber E.²,Smith Sita²,O’Kane Claire Y.²,Roady Tyler J.²,Moran Anne⁴,Scarry Alison⁴,Carroll Melissa⁴,Volinsky Leila⁴,Perez Gloria⁴,Patel Pinal²,Gabriel Stacey⁵,Lennon Niall J.⁵,Madoff Lawrence C.²⁶,Brown Catherine²,Smole Sandra C.²

Affiliation:

1. Department of Laboratory Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA

2. Massachusetts Department of Public Health, Jamaica Plain, Massachusetts, USA

3. Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

4. Lawrence General Hospital, Lawrence, Massachusetts, USA

5. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA

6. Division of Infectious Disease and Immunology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts, USA

Abstract

Rapid diagnostic tests (RDTs) for SARS-CoV-2 antigens (Ag) that can be performed at point of care (POC) can supplement molecular testing and help mitigate the COVID-19 pandemic. Deployment of an Ag RDT requires an understanding of its operational and performance characteristics under real-world conditions and in relevant subpopulations.

Funder

Massachusetts Department of Public Health

HHS | Centers for Disease Control and Prevention

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00083-21

Reference27 articles.

1. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2

2. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab

3. Becton Dickinson and Company. 2021. Package insert for the BD VeritorTM system for rapid detection of SARS-CoV-2. https://www.fda.gov/media/139755/download.

4. Quidel Corporation. 2020. Package insert for the Sofia SARS antigen FIA test. https://www.fda.gov/media/137885/download.

5. Abbott Laboratories. 2020. Package insert for the Abbott BinaxNOW COVID-19 Ag card. https://www.fda.gov/media/141570/download.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. At-Home Molecular Diagnostics: Just around the Corner or Years Away?;The Journal of Applied Laboratory Medicine;2024-01

2. Nanomaterial-Based Biosensors for SARS-CoV-2 and Future Epidemics;Analytical Chemistry;2023-10-12

3. The New Normal: Delayed Peak Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Loads Relative to Symptom Onset and Implications for Coronavirus Disease 2019 (COVID-19) Testing Programs;Clinical Infectious Diseases;2023-09-28

4. Assessment of the detection accuracy of SARS-CoV-2 rapid antigen test in children and adolescents: An updated meta-analysis;Journal of the Chinese Medical Association;2023-09-08

5. Evaluation of the analytical sensitivity of ACON and LumiraDx SARS-CoV-2 rapid antigen tests using samples with presumed Omicron variant;Diagnostic Microbiology and Infectious Disease;2023-09